Mitoxantrone,  a multiple sclerosis (MS)  drug that is already associated with a higher risk for leukemia and heart damage, may also raise a person’s risk of colorectal cancer, researchers at the University of Würzburg, in Germany, reported. If confirmed in larger studies, the findings indicate that colonoscopies should be conducted on MS patients after…
mitoxantrone
New research from Italy and Spain demonstrated that intense immunosuppression followed by autologous hematopoietic stem cell transplantation (AHSCT) was better than the medication mitoxantrone in treating severe cases of multiple sclerosis. The study appeared in the February 11, 2015, online issue of Neurology.  MS is characterized by an immune system attack on the…
Recommended Posts
- High Epstein-Barr antibody levels over time may aid MS diagnosis
- Sharing the lessons I’ve learned while living with MS
- With MS, it’s important to address mental health early in the process
- My journey with MS is unpredictable, yet driven by purpose
- MS study of genetic risk factors shows need for diverse data